Avoiding "Group Think": Barclays and UBS Analysts Are Bullish for These 10 Stocks

Looking for ideas on how to find stocks poised to outperform? One source is the sell-side ratings from various banks and firms, usually phrased positively as "buy" or "overweight."

Sell-side analysts produce research that is given to brokerage clients for their investment considerations. If the research is from a reliable analyst, a positive report can give a big boost to a stock's share price.

Researchers often cover a specific industry or sub-sector in order to become experts in their field. Their advanced knowledge helps them to utilize complex forecast models and ultimately deliver recommendations on stocks or other securities.

The recommendations are typically phrased as "buy," "sell," or "hold." Some companies issue an "overweight," "underweight," or "hold" rating.

The dangers of group think
Unfortunately, even the best of the best can get swept up by crowd mentality.

Imagine a group of three sell-side analysts. Two believe a company is a "buy," the third believe it is a "sell." It's reasonable to assume the group's final rating will be "buy," the opinion of the majority.

Sometimes markets will prove that the outlying opinion, in this case the "sell" rating, ends up being the correct one. This is a fundamental flaw of "group think," and it has led to several bad calls on Wall Street.

Business section: Investing ideas
In order to minimize the potential of group think, we wanted to find stocks that have received bullish ratings from more than one respected group of sell-side analysts.

For the following list, we took only the stocks both Barclays and UBS are bullish about.

Do you think these two firms are correct in recommending the stocks listed below?

List sorted by ratings date from UBS. (Click here to access free, interactive tools to analyze these ideas.)

1. FXCM (Nasdaq: FXCM  ) : Provides online foreign exchange (FX) trading and related services to retail and institutional customers Worldwide. On 01/11/2011, Barclays Capital had a Overweight rating on the stock. On 01/11/2011, UBS had a Buy rating on the stock.

2. Amdocs: Provides software and services to the communications, media, and entertainment industry service providers worldwide. On 01/28/2011, Barclays Capital had a Overweight rating on the stock. On 01/13/2011, UBS had a Buy rating on the stock.

3. Micron Technology (NYSE: MU  ) : Engages in the manufacture and marketing of semiconductor devices worldwide. On 01/03/2012, Barclays Capital had a Overweight rating on the stock. On 01/20/2011, UBS had a Buy rating on the stock.

4. Stanley Black & Decker: Provides hand tools, mechanical access solutions, and electronic security solutions. On 10/13/2011, Barclays Capital had a Overweight rating on the stock. On 02/18/2011, UBS had a Buy rating on the stock.

5. Textron (NYSE: TXT  ) : Operates in the aircraft, defense, automobile, industrial, and finance businesses worldwide. On 07/25/2011, Barclays Capital had a Overweight rating on the stock. On 02/22/2011, UBS had a Buy rating on the stock.

6. Demand Media: Operates as a content and social media company in the United States. On 09/16/2011, Barclays Capital had a Overweight rating on the stock. On 03/07/2011, UBS had a Buy rating on the stock.

7. Qlik Technologies (Nasdaq: QLIK  ) : Engages in the development, commercialization, and implementation of software products and related services that deliver data analysis and reporting solutions primarily in the Americas, and Europe. On 12/06/2011, Barclays Capital had a Overweight rating on the stock. On 03/07/2011, UBS had a Buy rating on the stock.

8. Baker Hughes (NYSE: BHI  ) : Baker Hughes Incorporated supplies wellbore related products, and technology services and systems for drilling, formation evaluation, completion and production, and reservoir technology and consulting to the oil and natural gas industry worldwide. On 05/09/2011, Barclays Capital had a Overweight rating on the stock. On 03/24/2011, UBS had a Buy rating on the stock.

9. HCA: HCA Holdings, offers health care services in the United States. On 04/19/2011, Barclays Capital had a Overweight rating on the stock. On 04/05/2011, UBS had a Buy rating on the stock.

10. Informatica: Provides enterprise data integration and data quality software and services worldwide. On 12/06/2011, Barclays Capital had an Overweight rating on the stock. On 04/29/2011, UBS had a Buy rating on the stock.

Interactive Chart: Press Play to compare changes in analyst ratings over the last two years for the stocks mentioned above. Analyst ratings sourced from Zacks Investment Research.


List compiled by Eben Esterhuizen, CFA. Kapitall's Eben Esterhuizen and Rebecca Lipman do not own any of the shares mentioned above.

The Motley Fool owns shares of Qlik Technologies and Textron. Motley Fool newsletter services have recommended buying shares of Informatica and Qlik Technologies. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 1757290, ~/Articles/ArticleHandler.aspx, 4/23/2014 4:04:15 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement